Novo Nordisk (NOVOb.CO) said on Tuesday it will stop a trial studying Ozempic to treat kidney failure in diabetes patients ahead of schedule because it was clear from an interim analysis that the treatment would succeed.
Pens for the diabetes drug Ozempic sit on a production line to be packaged at Danish drugmaker Novo Nordisk's site in Hillerod, Denmark, September 26, 2023. REUTERS/Tom Little/File Photosaid on Tuesday it will stop a trial studying Ozempic to treat kidney failure in diabetes patients ahead of schedule because it was clear from an interim analysis that the treatment would succeed.
Novo said the trial would be halted almost a year early based on a recommendation from the independent data monitoring board overseeing the study. Independent monitors can recommend stopping a trial early if there is clear evidence that a drug was going to succeed or fail based on interim analyses.
Since the start of the year, Novo has been riding a wave of demand for its highly effective semaglutide-based diabetes and weight-loss drugs that transformed the drugmaker into a $315 billion powerhouse.as Europe's most valuable listed company in September, and has seen its shares rise by around 17% since it announced in August that a large study had shown Wegovy had clear cardiovascular benefits.Coherent , a major U.S.
Indonesia Berita Terbaru, Indonesia Berita utama
Similar News:Anda juga dapat membaca berita serupa dengan ini yang kami kumpulkan dari sumber berita lain.
How Ozempic and Wegovy turned Novo Nordisk into a $400 billion companyHow Ozempic and Wegovy turned Novo Nordisk into a $400 billion company
Baca lebih lajut »
Exclusive: Novo Nordisk hires private U.S. firm to handle some Wegovy pen assembly -sourceNovo Nordisk (NOVOb.CO) has hired U.S. private contract manufacturer PCI Pharma Services to handle assembly and packaging of Wegovy, a source familiar with the matter said, as it races to boost output of the weight-loss drug to meet demand.
Baca lebih lajut »
Tamra Judge fires back at 'disgusting' theory that Ozempic use led to intestinal obstructionTamra Judge hospitalized for intestinal obstruction: ‘Praying I won’t need surgery’
Baca lebih lajut »
RHOC's Tamra Judge Slams 'Disgusting' Ozempic Claims After Suffering Intestinal ObstructionThe Real Housewives of Orange County's Tamra Judge clapped back at critics accusing her of using weight-loss drug Ozempic amid a recent health scare for ongoing intestinal problems.
Baca lebih lajut »
Ozempic and Wegovy aren’t affecting PepsiCo’s business much — but this trend isStock sold off last week after Walmart said Wegovy and Ozempic were leading customers to buy fewer groceries and cut back on calories
Baca lebih lajut »
Ozempic Won't Kill Americans' Taste for Sugary SnacksInvestors' fears that the new weight-loss drugs will hamstring Big Food companies are overblown.
Baca lebih lajut »